Welcome to our dedicated page for NextGen Healthcare news (Ticker: NXGN), a resource for investors and traders seeking the latest updates and insights on NextGen Healthcare stock.
NextGen Healthcare, Inc. (symbol: NXGN) is a leading provider of integrated clinical, financial, and connectivity solutions within the healthcare sector. As a wholly owned subsidiary of Quality Systems, Inc., NextGen Healthcare focuses on improving the efficiency and quality of care provided by primary care physicians, specialist physicians, health systems, and dental provider organizations.
The company offers a robust suite of products and services designed to facilitate collaborative care and enhance patient engagement. Their solutions support key healthcare initiatives such as the patient-centered medical home, accountable care organizations, and health information exchange.
NextGen Healthcare’s portfolio includes electronic health records (EHR), practice management systems, revenue cycle management, and population health services. These tools help healthcare providers streamline operations, maintain regulatory compliance, and achieve better financial performance.
Recent achievements include advancements in their EHR platform to incorporate new interoperability standards, enhancing their practice management systems to offer more robust reporting and analytics capabilities, and expanding their telehealth solutions to meet the growing demand for remote patient care.
The company is financially stable, with a strong balance sheet and a commitment to continuous innovation. NextGen Healthcare maintains strategic partnerships with key players in the healthcare industry to deliver cutting-edge solutions and services that meet the evolving needs of healthcare providers.
By leveraging advanced technology and a comprehensive product suite, NextGen Healthcare stands out as a pivotal player in the healthcare IT landscape, driving better outcomes for patients and healthcare systems alike.
NextGen Healthcare (Nasdaq: NXGN) has reported findings from an independent study commissioned by HEALTHeLINK, demonstrating significant benefits of its Population Health solutions integrated with value-based care models. Key results include a 33% reduction in hospital stays, a 30% decrease in re-admission rates, a 24.1% reduction in admissions, and a 21% drop in outpatient surgeries. These results highlight the effectiveness of NextGen’s solutions in improving patient care and supporting healthcare providers in transitioning to value-based care.
NextGen Healthcare (NASDAQ: NXGN) has entered a definitive agreement to acquire TSI Healthcare for $68 million, effective November 30, 2022. The deal includes up to $22 million in contingent earnout based on financial targets through March 31, 2025. This acquisition is expected to boost revenue by $10-$12 million within fiscal 2023 and enhance adjusted EBITDA and cash flow within a year. The integration emphasizes NextGen's expansion into specialties like rheumatology and cardiology, building on a long-standing partnership with TSI Healthcare.
NextGen Healthcare, Inc. (Nasdaq: NXGN) announced participation in the Piper Sandler 34th Annual Healthcare Conference. The management's fireside chat is scheduled for Wednesday, Nov. 30 at 1 p.m. Eastern time. A recording of the event will be accessible on investor.nextgen.com and archived for 90 days. NextGen Healthcare focuses on innovative cloud-based healthcare technology solutions that enhance ambulatory healthcare and improve patient outcomes.
NextGen Healthcare (Nasdaq: NXGN) will participate in the Stephens Annual Investment Conference on November 15 at 3 p.m. Eastern Time. The event will feature a fireside chat format with the company's management. A recording of the session will be accessible at investor.nextgen.com and archived for 90 days post-event. NextGen Healthcare is recognized for its innovative, cloud-based healthcare technology solutions, aiming to enhance clinical quality and patient experience.
NextGen Healthcare, Inc. (NASDAQ: NXGN) successfully held its 25th annual User Group Meeting in Nashville from November 7-9, 2022, attracting around 1,800 healthcare professionals. The conference focused on improving healthcare outcomes through technology. Key speakers included innovation theorist John Nosta and Paralympic medalist Amy Purdy. Four healthcare providers received the 2022 Excellence in Healthcare Awards for their outstanding use of NextGen solutions. The event highlighted NextGen's commitment to advancing healthcare technology and its impact on community health.
NextGen Healthcare, Inc. (Nasdaq: NXGN) commenced its 25th annual User Group Meeting (UGM) in Nashville, attracting nearly 2,000 attendees for the first in-person gathering since 2019. The event, running until Nov. 9, emphasizes the role of technology in enhancing healthcare outcomes and alleviating physician burnout. CEO David Sides highlighted the company's innovative solutions aimed at future healthcare practices. UGM 22 includes over 125 educational sessions, focusing on various aspects like value-based care and financial stability, fostering a collaborative healthcare community.
NextGen Healthcare (Nasdaq: NXGN) has been selected by Cherry Health, Michigan's largest Federally Qualified Health Center, to provide its NextGen Enterprise EHR and practice management solution. The decision followed a thorough evaluation focusing on functionality and integrated solutions to enhance patient-provider interactions. With over 800 healthcare professionals serving more than 65,000 patients annually, Cherry Health aims to alleviate provider burnout and streamline operations using NextGen's customizable platform, which includes tools like Virtual Visits and Managed Cloud Services.
NextGen Healthcare (NASDAQ: NXGN) has priced a private offering of $230 million in 3.75% convertible senior notes due 2027, increased from an initial $200 million. Settlement is set for November 1, 2022. The notes will accrue interest payable semi-annually and grant holders certain conversion rights beginning August 16, 2027. The estimated net proceeds of approximately $222.8 million will be used for general corporate purposes and to repurchase $40 million of its common stock. The initial conversion price is approximately $25.68 per share, reflecting a 35% premium over the last closing price.
NextGen Healthcare (NASDAQ: NXGN) announced plans to offer $200 million in convertible senior notes due 2027 in a private offering aimed at qualified institutional buyers. An additional $30 million could be offered at the purchasers' option. The notes will accrue semi-annual interest and may be converted to cash or stock. Up to $50 million of proceeds will be used to repurchase common stock, potentially affecting share prices. The offering is not registered under the Securities Act. No assurances on final offering terms have been provided.
NextGen Healthcare, Inc. (Nasdaq: NXGN) reported a strong performance for the fiscal second quarter ending September 30, 2022, with total revenue of $159.4 million, up 7% year-over-year. Recurring revenue increased 6% to $143.5 million, while non-recurring revenue rose 17% to $15.9 million. The company achieved a fully diluted net income per share of $0.20, compared to a net loss of $0.10 in the prior year. Revised fiscal 2023 guidance now anticipates revenue of $630 to $640 million and non-GAAP EPS of $0.93 to $0.99.
FAQ
What is the market cap of NextGen Healthcare (NXGN)?
What is NextGen Healthcare, Inc.?
What services does NextGen Healthcare offer?
Who are the primary users of NextGen Healthcare's solutions?
What recent advancements has NextGen Healthcare made?
What healthcare initiatives does NextGen Healthcare support?
Is NextGen Healthcare financially stable?
Who is the parent company of NextGen Healthcare?
What is the stock symbol for NextGen Healthcare?
How does NextGen Healthcare enhance patient engagement?
What strategic partnerships does NextGen Healthcare maintain?
